Apelin-13 vs Intermedin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Apelin-13 is the most biologically active isoform of the apelin peptide family, endogenous ligands for the APJ receptor (also called APLNR). Apelin peptides are produced throughout the body, with the heart, lung, brain, and adipose tissue expressing particularly high levels....
Calculate Apelin-13 dose →Intermedin (also called Adrenomedullin 2, AM2) is a 47-53 amino acid peptide belonging to the calcitonin gene-related peptide (CGRP)/adrenomedullin superfamily. Discovered in 2004, intermedin is widely expressed in the heart, lung, kidney, gut, and brain....
Calculate Intermedin dose →| Parameter | Apelin-13 | Intermedin |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Clinical | Preclinical Research |
| Half-Life | < 5 min (plasma) | ~15-30 minutes |
| Typical Dose | 50-300 nmol/kg | 1-100 pmol/kg/min infusion (animal) |
| Frequency | Variable | Acute infusion |
| Route | Intravenous (research), Subcutaneous | IV (research); SC in some studies |
| FDA Status | Not approved | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.